Pricing Log in Create free account
Friday 6 November 2026 Export RDY’s income statement to Excel — free account

Dr. Reddy's Laboratories Ltd

RDY Healthcare Drug Manufacturers Specialty & Generic

Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.

Revenue
−10.1%
EPS
−36.8%
Free cash flow
−70.5%
Total debt
+14.1%

Quarter to September 2026, against a year earlier

14.86 0.33 +2.27%
Market cap
$12.1B
P/E
44.4×
Fwd P/E
30.7×
Dividend yield
0.00%
F-score
4/9
Altman Z
5.26
Beneish M
−2.59
Dividend safety
74/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Dr. Reddy's Laboratories Ltd (RDY) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Dr. Reddy's Laboratories Ltd (RDY) trades at a EV/Sales of 3.6×. Over the past ten years it has ranged from 2.3× (August 2017) to 18.5× (October 2024); the current reading is higher than 68% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 2.9× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 3.2× 12.01%
FY2025 2.8× (17.55%)
FY2024 3.5× 16.70%
FY2023 3.0× (7.95%)
FY2022 3.2× (17.50%)
FY2021 3.9× 36.20%
FY2020 2.9× (8.02%)
FY2019 3.1× 16.42%
FY2018 2.7× (19.06%)
FY2017 3.3× 1.28%

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.1× (4.12%)
Jun 2026 3.3× 2.64%
Mar 2026 3.2× 8.96%
Dec 2025 2.9× 0.30%
43 more quarters

Against its own ten years

Low 2.3× High 18.5×
Ten-year median 3.2×
Current reading's percentile 73

EV/Sales against peers

Company EV/Sales
VTRS Viatris Inc. compare 2.3×
HIMS Hims & Hers Health, Inc. compare 2.4×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 3.0×
ELAN Elanco Animal Health Incorporated compare 3.0×
RDY Dr. Reddy's Laboratories Ltd 3.6×
LNTH Lantheus Holdings, Inc. compare 4.1×
NBIX Neurocrine Biosciences, Inc. compare 4.4×
ALKS Alkermes plc compare 4.7×
KNSA Kiniksa Pharmaceuticals International, plc compare 6.7×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RDY